Welcome to our dedicated page for McEwen SEC filings (Ticker: MUX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The McEwen Inc. (MUX) SEC filings page on Stock Titan provides direct access to the company’s U.S. regulatory disclosures, together with AI-assisted summaries to help interpret complex documents. As a Colorado corporation listed on the New York Stock Exchange, McEwen files current reports on Form 8-K and other periodic reports that describe material events affecting its gold, silver and copper business across the Americas.
In recent Form 8-K filings, McEwen has reported on a range of topics, including the business combination with Canadian Gold Corp. that added the Tartan Mine Project in Manitoba, the extension of the Environmental Impact Assessment for the El Gallo Mine in Mexico, and strategic investments such as the share exchange agreement to acquire an interest in Paragon Geochemical Laboratories. Other 8-Ks discuss financing transactions like flow-through share offerings, appointments of senior executives, and technical and feasibility milestones at the Los Azules copper project in San Juan, Argentina.
Through this page, users can review McEwen’s filings to see how the company describes its operations at the Gold Bar Mine Complex in Nevada, the Fox Complex in Ontario, the San José Mine in Argentina, the El Gallo Mine in Mexico and its 46.4% interest in McEwen Copper. AI-powered tools highlight key sections of lengthy filings, such as risk factor discussions, descriptions of material agreements, and summaries of technical and permitting developments.
Investors researching MUX can use the filings page to locate quarterly and annual reports when available (Forms 10-Q and 10-K), current reports on Form 8-K, and exhibits referenced in those filings. The inclusion of insider and financing-related disclosures, where filed, helps users understand equity issuances, ownership changes and other regulatory events that may influence the company’s capital structure and project funding.
McEwen Inc. announced the closing of its previously announced business combination with Canadian Gold Corp. by way of a statutory plan of arrangement. The closing followed approval by Canadian Gold shareholders on December 5, 2025 and a final order from the British Columbia Supreme Court on December 10, 2025, including an amendment order.
The company also entered into an amendment to the arrangement agreement that requires shareholder approval before issuing any McEwen common shares to Chairman and CEO Robert McEwen in exchange for his Canadian Gold shares, to comply with New York Stock Exchange requirements. McEwen plans to file the amendment as an exhibit to its next Form 10-K and has furnished a press release with further details as an exhibit to this report.
McEwen Inc. reported that the Mexican government has granted an extension of its Environmental Impact Assessment for the El Gallo Mine. This regulatory approval is a key step that is expected to allow the company to start Phase 1 mill construction, which McEwen currently plans to begin in mid-2026. The company highlighted that this development is described in more detail in a press release furnished as an exhibit, and it also reminded readers that future outcomes remain subject to the usual operational, regulatory, and market risks outlined in its risk factor disclosures.
McEwen Inc. officer Carmen L. Diges, the company’s General Counsel and Corporate Secretary, reported the vesting and cash settlement of several restricted stock unit (RSU) awards on December 20, 2025.
RSUs granted on June 29, 2025 vested as to 3,370 units, and RSUs granted on November 10, 2025 vested as to 1,470 units, with all vested amounts settled for cash rather than shares. Additional RSUs granted on August 11, 2025 and September 8, 2025 had their second vesting events accelerated to December 20, 2025, resulting in 1,300 and 533 units vesting, respectively, also settled for cash.
The remaining RSUs from these grants are scheduled to vest on future dates in 2026, reflecting ongoing equity-based compensation for this executive.
McEwen Inc. director Ian J. Ball reported equity compensation activity involving the company’s common stock. On December 20, 2025, he acquired 160 shares of common stock through an exempt transaction coded “M,” leaving him with 160 common shares held directly after the transaction.
On the same date, 310 restricted stock units (RSUs) vested from an award originally granted on November 10, 2025. Each RSU represents a right to receive one share of common stock or its cash value, at the discretion of the Compensation, Nominating & Corporate Governance Committee. Of the 310 vested RSUs, 150 shares were settled in cash. The remaining RSUs from this grant are scheduled to vest in two equal installments on June 29, 2026 and December 20, 2026, and Ball reported 620 RSUs beneficially owned directly after the transaction.
McEwen Inc.'s VP Finance reported equity compensation activity involving restricted stock units and common shares. On December 20, 2025, the officer exercised restricted stock units (coded "M" for conversion) that delivered 588 and 275 shares of McEwen Inc. common stock in two transactions. After these transactions, the officer directly owned 3,691 and 3,966 common shares, respectively.
The filing also details two restricted stock unit awards that converted into common stock on December 20, 2025. One award covered 1,266 shares of common stock and another covered 533 shares, each at an exercise price of $0. The vesting schedules for both awards had previously been amended to accelerate a vesting event from December 28, 2025 to December 20, 2025, with a portion of the vested units settled in cash and the remaining units scheduled to vest on June 28, 2026.
McEwen Inc. Chief Financial Officer Perry Ing reported the vesting and settlement of several restricted stock unit (RSU) awards on December 20, 2025. Multiple RSU grants converted into shares of McEwen common stock through automatic transactions coded “M,” increasing his directly held stake over the course of the day to 46,594 shares of common stock.
The RSU awards were originally granted on June 29, 2025; November 10, 2025; August 11, 2025; and September 8, 2025. Portions of these awards vested on December 20, 2025, with some of the vested units settling in cash (including 2,537, 1,247, 999 and 428 units from the respective grants) and the remainder settling in shares. The filing notes that remaining unvested RSUs are scheduled to vest in 2026, and certain vesting dates were accelerated from late December 2025 to December 20, 2025.
McEwen Inc. officer reports accelerated RSU vesting and cash settlement. A company officer, listed as VP Corporate Development, reported activity in restricted stock units tied to McEwen Inc. common stock. One RSU grant made on August 11, 2025 had its vesting schedule amended so the second vesting event moved from December 28, 2025 to December 20, 2025, causing 1,200 units to vest and be settled entirely in cash on that date, with remaining units scheduled to vest on June 28, 2026. A second RSU grant made on September 8, 2025 was amended in the same way, leading to 500 units vesting and being settled for cash on December 20, 2025, with the balance also scheduled to vest on June 28, 2026. Each RSU represents a contingent right to receive one share of common stock or its cash value, at the discretion of the board committee.
McEwen Inc. director and Chief Operating Officer William M. Shaver reported the vesting of several restricted stock unit awards and related acquisitions of common shares. On December 20, 2025, restricted stock units granted on June 29, 2025 vested as to 11,740 shares, those granted on November 10, 2025 vested as to 5,700 shares, and earlier grants from August 11, 2025 and September 8, 2025 vested as to 2,100 and 867 shares, respectively. Each unit converts into one share of common stock or its cash value at the discretion of the company’s Compensation, Nominating & Corporate Governance Committee.
Following these transactions, Shaver directly owned 149,200 shares of McEwen Inc. common stock. The remaining portions of these awards are scheduled to vest on specified future dates in 2026 according to each grant’s vesting schedule.
McEwen Inc. disclosed an unregistered equity financing and a pending share issuance tied to a prior agreement. The company entered into definitive agreements to sell 565,000 shares of common stock as flow-through shares under Canadian tax rules, split between 215,000 Canadian Exploration Expense shares at US$23.80 and 350,000 Canadian Development Expense shares at US$20.90. The exploration tranche closed on December 19, 2025, while the development tranche is expected to close in January 2026, generating approximately $12.4 million in net proceeds for exploration and development work.
McEwen also describes a Share Exchange Agreement with Britannia Life Sciences Inc., under which it must issue additional common shares valued at CAD$11,340,035, calculated using a 20-day volume-weighted average price and a Bank of Canada exchange rate. Both the flow-through Offering and the Payment Shares rely on private-offering exemptions from U.S. registration, including Section 4(a)(2), Regulation D, and Regulation S.
McEwen Inc. (MUX) reported insider equity activity by its VP Corporate Development. On November 10, 2025, the officer acquired a total of 790 shares of common stock through conversions of restricted stock units, increasing his directly held stake to 4,604 shares.
These transactions came from vesting of two restricted stock unit awards originally granted on August 11, 2025 and September 8, 2025. For the first award, 1,200 units vested on November 10, 2025, with 642 shares settling in cash and the rest in stock, and the remaining units vest in two equal installments on December 28, 2025 and June 28, 2026. For the second award, 500 units vested on November 10, 2025, with 268 shares settling in cash, and the balance vesting on the same two future dates.
FAQ
What is the current stock price of McEwen (MUX)?
What is the market cap of McEwen (MUX)?
